Conclusions
toxicities
Weekly schedule of cisplatin and nab‐paclitaxel in combination with concurrent radiotherapy showed manageable toxicities and promising antitumor activity in patients with locally advanced ESCC. The recommended dose of nab‐paclitaxel for further studies is 75 mg/m
Hui Jiang, Qiaoqiao Li, and Baoqing Chen should be considered joint first author.